Item 5.07 Submission of Matters to a Vote of Security Holders
Charles River Laboratories International, Inc. (the "Company") held its Annual Meeting of Shareholders onMay 10, 2022 . For more information on the following proposals, see the Company's proxy statement datedMarch 30, 2022 . At the Company's Annual Meeting, the following proposals were adopted by the votes specified below: (a) The following ten (10) directors were elected to serve until our 2023 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below: Number of Shares Voted For Number of Shares Number of Shares Broker Non-Votes Voted Against Abstained James C. Foster 42,534,751 2,405,964 55,803 2,058,945 Nancy C. Andrews 44,365,867 615,186 15,465 2,058,945 Robert J. Bertolini 44,352,102 628,678 15,738 2,058,945 Deborah T. Kochevar 42,451,764 2,502,610 42,144 2,058,945 George Llado, Sr. 43,842,377 1,133,006 21,135 2,058,945 Martin W. Mackay 36,951,004 8,029,626 15,888 2,058,945 George E. Massaro 42,907,679 2,074,825 14,014 2,058,945 C. Richard Reese 43,127,533 1,854,566 14,419 2,058,945 Richard F. Wallman 43,636,549 1,346,183 13,786 2,058,945 Virginia M. Wilson 44,272,229 708,615 15,674 2,058,945
(b) The shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers.
For Against Abstain Broker Non-Votes 39,792,720 5,179,352 24,446 2,058,945
(c) The shareholders approved the ratification of the appointment of
For Against Abstain Broker Non-Votes 44,673,788 2,366,772 14,903 0
2
--------------------------------------------------------------------------------
© Edgar Online, source